SCHEDULE 13G/A: Armistice Capital and Steven Boyd Disclose 9.99% Stake in Cosmos Health Inc.
Beneficial Ownership Report
Armistice Capital, LLC and its managing member Steven Boyd have disclosed a beneficial ownership of 9.99% in Cosmos Health Inc., totaling 2,508,013 shares of common stock as of December 31, 2024.
Summary
- Armistice Capital, LLC and Steven Boyd (collectively, the "Reporting Persons") have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Cosmos Health Inc.
- As of December 31, 2024, the Reporting Persons collectively beneficially own 2,508,013 shares of Cosmos Health Inc. Common Stock.
- This ownership represents 9.99% of the total outstanding shares of Cosmos Health Inc.'s common stock.
- Armistice Capital, LLC, a Delaware entity, acts as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.
- Steven Boyd, a U.S. citizen, is the managing member of Armistice Capital, LLC and is deemed to beneficially own the shares held by the Master Fund.
- The Reporting Persons hold shared voting power and shared dispositive power over all 2,508,013 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a standard regulatory disclosure of beneficial ownership and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or prospects. It is a neutral factual report.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of significant beneficial ownership by an institutional investor, Armistice Capital, and its principal, Steven Boyd, in a publicly traded company, Cosmos Health Inc. It reflects an investment position rather than operational or strategic industry trends.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which can influence market perception and trading activity. The disclosure of a nearly 10% stake by Armistice Capital and Steven Boyd indicates a notable investment position.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires the filing of this statement, indicating the beneficial ownership position. |
| 02/14/2025 | Date the Schedule 13G/A Amendment No. 2 was signed and filed. |
Keywords
Cosmos Health Inc., Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, SEC Filing, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.